Up to now, hematopoietic stem cells (HSCs) that contribute to all mature blood cell lineages in adults still cannot be efficiently regenerated in vitro, at least in part due to the insufficient understanding of their physiological developmental trajectories and the underlying precise regulatory mechanisms. In mouse embryos, the first HSCs are believed to be derived from a specialized arterial endothelial population named hemogenic endothelial cells (HECs) in the mid-gestational aorta-gonad-mesonephros region, and then via the intermediates of two types of pre-HSCs (CD45 − T1 pre-HSCs and CD45 + T2 pre-HSCs). The transient and dynamic process is termed endothelial-to-HSC transition. After that, newly emerged HSCs colonize the fetal liver (FL) for proliferation and then migrate to the bone marrow niche for lifelong hematopoiesis 1 , 2 , 3 .